您的位置：
首页
>
农业专利
>
详情页
BLOQUEURS DES SREBP DESTINES A L'UTILISATION DANS LE TRAITEMENT DE LA FIBROSE HEPATIQUE, LE CHOLESTEROL ELEVE ET LA RESISTANCE A L'INSULINE
专利权人:
INC.;MEDIVATION TECHNOLOGIES
发明人:
BERNALES, SEBASTIAN,LINDQUIST, JEFFREY,GUHA, MAUSUMEE
申请号：
CA2978627
公开号：
CA2978627A1
申请日:
2016.03.03
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
This disclosure provides compounds and methods of using those compounds to treat liver fibrosis, including liver fibrosis which is a precursor to, is concurrent with, is associated with, or is secondary to nonalcoholic steatohepatitis (NASH)； elevated cholesterol levels, and insulin resistance.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
SREBP blocker for use in treating liver fibrosis, elevated cholesterol and insulin resistance
СПОСОБ ОЦЕНКИ ФИБРОЗА ПЕЧЕНИ
Pyrethrin is used to treat corticopulmonary fibrosis, including prevention, disease resistance, termination or use, and cytochrome Cypa2 inhibitors, including fluvoxamide, are also used.
UNE INTERLEUKINE 15 RECOMBINANTE EST UN AGENT THÉRAPEUTIQUE POUR LE TRAITEMENT DE L'HYPERACTIVITÉ, LA RÉSISTANCE (OBSTRUCTION) ET LA FIBROSE DES VOIES RESPIRATOIRES DANS L'ASTHME CHRONIQUE
POLYPEPTIDE, DERIVATIVES THEREOF, AND APPLICATION THEREOF IN PREPARATION OF DRUGS HAVING RESISTANCE TO PULMONARY FIBROSIS
